![Yasunori Kaneko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 30 M $ in data 30/06/2026
Dr. Yasunori Kaneko is a Lead Independent Director at Arcus Biosciences, Inc. He is on the Board of Directors at Arcus Biosciences, Inc. and Provigate KK.
Dr. Kaneko was previously employed as an Independent Outside Director by Nippon Paint Holdings Co., Ltd., an Independent Director by H.U.
Group Holdings, Inc., a Managing Director by Skyline Management LLC, a Managing Director by Skyline Venture Partners LP, a Chief Financial Officer & VP-Business Development by Tularik, Inc., a Chief Financial Officer & Senior Vice President by Isis Pharmaceuticals, Inc., and a Head-Corporate Finance by Paribas Capital Markets.
He also served on the board at Guava Technologies, Inc., KAI Pharmaceuticals, Inc. and LeukoSite, Inc. He received his undergraduate degree from Keio University, an MBA from Stanford Graduate School of Business and a doctorate degree from Keio University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 957.955 ( 0,76% ) | 30 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/05/2015 |
Provigate KK
 Provigate KK Medical SpecialtiesHealth Technology Manufactures and sells tear sugar measurement devices | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| NIPPON PAINT HOLDINGS CO., LTD. | Direttore/Membro del Consiglio | 01/03/2020 |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management invests in companies located in the United States. The firm focuses on companies operating in the fields of healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research and healthcare information technology. It participates in financing for early stage and later stage transactions with an investment size between USD 15 and 25 million. | Investitore di Private Equity | 01/01/2019 |
Skyline Venture Partners LP
 Skyline Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01/01/2019 |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Direttore/Membro del Consiglio | 01/01/1999 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Direttore Finanziario/CFO | 01/01/1998 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 14 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Nippon Paint Holdings Co., Ltd.
 Nippon Paint Holdings Co., Ltd. Industrial SpecialtiesProcess Industries Manufactures and distributes paints and fine chemicals | Process Industries |
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management invests in companies located in the United States. The firm focuses on companies operating in the fields of healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research and healthcare information technology. It participates in financing for early stage and later stage transactions with an investment size between USD 15 and 25 million. | Finance |
Keio University
 Keio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guava Technologies, Inc.
 Guava Technologies, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes cytometry systems for cellular analyses | Health Technology |
H.U. Group Holdings, Inc.
 H.U. Group Holdings, Inc. Medical/Nursing ServicesHealth Services Operates as a holding company with interests in manufacturing of diagnostic drugs and equipments | Health Services |
Skyline Venture Partners LP
Skyline Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Paribas Capital Markets
 Paribas Capital Markets Investment Banks/BrokersFinance Provides brokerage services | Finance |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Provigate KK
Provigate KK Medical SpecialtiesHealth Technology Manufactures and sells tear sugar measurement devices | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
